MLP SAĞLIK HİZMETLERİ A.Ş.

Proxy Solicitation & Information Statement • May 13, 2024

POWER OF ATTORNEY

MLP SAĞLIK HİZMETLERİ A.Ş.

I/we hereby appoint .............................................................., further identified below, as my/our representative to represent me/us and vote, submit proposals and sign documents on my/our behalf, within the framework of the instructions below, at the annual general assembly meeting of MLP Sağlık Hizmetleri A.Ş., scheduled for 10:00 a.m. on May 13, 2024, Monday, at the address of "Liv Hospital Vadistanbul Ayazağa Mahallesi, Kemerburgaz Caddesi, Vadistanbul Park Etabı, 7F Blok Sarıyer, İstanbul".

Name, Surname / Commercial Title of the Proxy

....................................................................................................................................................... Turkish

Identification / Tax Number, Trade Registration No. and MERSIS No. of the Proxy .......................................................................................................................................................

(*) For foreign proxies equivalent of the required information must be provided

A) SCOPE OF REPRESENTATIVE AUTHORITY

For Sections 1 and 2 provided below either (a), (b) or (c) must be chosen to indicate the

scope of representative authority.

1.With Respect to the Agenda Items:

a) The Proxy is authorized to vote at its own discretion.

b) The Proxy is authorized to vote in accordance with the proposals of the Company management.

c) The Proxy is authorized to vote in accordance with the instructions below.

Instructions:

If the Shareholder chooses option (c) above, the Shareholder will provide instructions to the Proxy by indicating its vote on each agenda item and by also indicating its dissenting opinion, if any, for the agenda items voted against.

	Agenda Items	In	Against	Dissenting Opinion
		Favor
1.	Opening of the meeting and establishment of the
	Board of the General Assembly,
2.	Authorization of the Board of the General
	Assembly to sign the Meeting Minutes and the
	List of Attendees,
3.	Reading out and discussion of the Annual Report
	of the Board of Directors for the year 2023,
4.	Reading out the report of the Independent Audit
	Company for the fiscal year 2023,
5.	Reading out, discussion and approval of the
	Financial Statements for the fiscal year 2023
	prepared in accordance with the regulations of
	CMB,
6.	Acquittal of the members of the Board of
	Directors separately regarding their operations
	and transactions in 2023,
7.	Discussion and approval of the proposal of the
	Board of Directors on profit distribution,
8.	Submitting the decision taken by the Board of
	Directors of our Company at its meeting dated
	25.05.2022 regarding the increase of the fund

allocated for the repurchase programme, which
was initiated in order to support the healthy price
formation of MPARK shares in the share market,
to contribute to the stability of the share price and
its formation in accordance with its real value, to
protect the shareholders and to offer them a more
attractive long-term investment opportunity, to
2,150,000,000,00- Turkish Liras for the
information of the shareholders,
9. In accordance with the Capital Markets
regulations, the Turkish Commercial Code and
Article 12 of the Company's Articles of
Association, Mr. Temel Güzeloğlu and Mr. Temel
Güzeloğlu, who were nominated as Independent
Board Members by the Board of Directors on
22.02.2024 in place of the Independent Board
Members whose term of office has expired. Temel
Güzeloğlu and Mr. Betül Ebru Edin, who were
nominated as Independent Board Members by the
Board of Directors on February 22, 2024, for the
approval of the General Assembly and to discuss
and resolve on the determination of their
remuneration,
10. Election of Board of Directors members,
11. In accordance with Article 399 of Turkish
Commercial Code No. 6102, Article 24 of the
Company Articles of Association, and relevant
regulations of Capital Markets Law No. 6362, it
is proposed to submit to the approval of the
shareholders the appointment of DRT
Independent Audit and Certified Public
Accountant Financial Advisory Inc. as the
Independent Auditor for the examination of the
Company Financial Statements and Reports for
the year 2024,
12. Informing the shareholders on the donations made
by the Company in 2023 in accordance with the
regulations laid down by the Capital Markets
Board and Article 4 of the Company's Articles of
Association and discussion and approval of the
Board of Directors' proposal on the ceiling of
donations to be made in 2024,
13. According to the regulations laid down by the
Capital Markets Board, informing the
shareholders on any income and benefits obtained
by the Company by granting collaterals, pledges
and mortgages in favor of third persons,
14. Informing the General Assembly of the
transactions, if any, within the context of Article
1.3.6. of the Corporate Governance Communique
(II-17.1.) of the Capital Markets Board,
15. Authorization of the members of the Board of
Directors about the transactions and operations in
the context of the Articles 395 and 396 of the
Turkish Commercial Code,
16. Petitions and requests.

(*) Agenda items for the General Assembly will be listed one by one. If the minority shareholders propose another draft resolution, this draft resolution will also be indicated here.

2. Special Instructions Regarding Other Matters Arising During the Meeting Especially the Exercise of Minority Rights:

a) The Proxy is authorized to vote at its own discretion.

b) The Proxy is not authorized to vote on these matters.

c) The Proxy is authorized to vote in accordance with the special instructions below.

SPECIAL INSTRUCTIONS; Special instructions to the Proxy, if any, will be indicated here. .......................................................................................................................................................

B) The Shareholder will indicate the shares it wishes the Proxy to represent by choosing one of the following.

1. I approve the representation of the shares detailed below by the Proxy. a) Series and Order:* …………………………………………………………………................ b) Number:** …………………………………………………………………............................ c) Amount-Nominal Value of the Shares: ………………………………………………….. d) Information on any Privileges attached to the Shares: ………………………….. e) Bearer or Registered:* …………………………………………………………………......... f) Ratio Against the Entire Number of Shares and Voting Rights of the Shareholder: ………………………………………………………………….............................................. * Not required for dematerialized shares.

** For dematerialized shares group information will be provided instead of number.

2. I approve the representation of all my shares indicated in the list of attendees to be prepared by the CRA one day prior to the General Assembly by the Proxy. NAME, SURNAME OR COMMERCIAL TITLE OF THE SHAREHOLDER (*)

....................................................................................................................................................... Turkish Identification / Tax Number, Trade Registration No. and MERSIS No. of the Shareholder: ……………………………………………………………………………………………………………………… ………………. Address of the Shareholder: ……………………………………………………………………………………………………………………… ………………. (*) For foreign shareholders equivalent of the required information must be provided

SIGNATURE SEAL / SIGNATURE